# PROCEPT BioRobotics Corp (PRCT)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/procept-biorobotics-corp/ JSON: https://steadybase.io/company/procept-biorobotics-corp.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: PROCEPT BioRobotics Corp
- Ticker: PRCT (Nasdaq)
- SEC CIK: 0001588978
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: San Jose, CA
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: procept-biorobotics.com
- LinkedIn: https://www.linkedin.com/company/procept-corporation
- Next earnings date: Feb 9, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $308.1M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/0001588978-26-000009-index.html
- Operating income: -$103.9M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/0001588978-26-000009-index.html
- Net income: -$95.6M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/0001588978-26-000009-index.html
- SG&A: $228.8M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/0001588978-26-000009-index.html
- Employees: 888 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/prct-20251231.htm
- Shares outstanding: 57,536,121 as of Oct 29, 2026 (10-Q filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000039/0001588978-26-000039-index.html
- Auditor: Pricewaterhousecoopers LLP, San Jose, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/prct-20251231.htm

## Business

We are a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, manufacture and sell the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/prct-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $308.1M | -$103.9M | -$95.6M | $228.8M |
| Dec 31, 2024 | $224.5M | -$96.6M | -$91.4M | $171.4M |
| Dec 31, 2023 | $136.2M | -$109.2M | -$105.9M | $131.8M |
| Dec 31, 2022 | $75.0M | -$80.7M | -$87.2M | $88.8M |
| Dec 31, 2021 | $34.5M | -$54.2M | -$59.9M | $51.0M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/procept-biorobotics-corp.json

## Officers and directors

- Larry Wood, Chief Executive Officer. Source: 8-K filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000036/prct_q32026earningsrelease.htm
- Larry L. Wood, President, CEO. LinkedIn: https://linkedin.com/in/larry-wood-6b6020147. Source: Form 4 filed Aug 10, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000162828026054970/0001628280-26-054970-index.htm
- Kevin Waters, EVP, CFO. LinkedIn: https://linkedin.com/in/kevin-waters-98b6603. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000165377126000002/0001653771-26-000002-index.htm
- Alaleh Nouri, EVP, CLO, CORP. SEC.. LinkedIn: https://linkedin.com/in/alalehnouri. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000159941826000002/0001599418-26-000002-index.htm
- Barry L. Templin, EVP, Chief Technology Officer. LinkedIn: https://linkedin.com/in/barry-templin-38003a5. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000032/0001588978-26-000032-index.htm
- Pooja Sharma, Chief Strat/Marketing Officer. Source: Form 4 filed Aug 14, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000162828026057156/0001628280-26-057156-index.htm
- Antal Desai, Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm
- Daniel Puckett, Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm
- Elisabeth Little, Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm
- Frederic Moll, M.D., Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm
- Mary Garrett, Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm
- Thomas M. Prescott, Board member (per proxy). Source: DEF 14A filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm

## Recent 8-K events

- Nov 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000036/prct-20261104.htm
- Oct 2, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/prct-20261002.htm
- Sep 24, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000034/prct-20260923.htm
- Aug 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000028/prct-20260804.htm
- Jun 10, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000026/prct-20260609.htm
- Apr 29, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000020/prct-20260429.htm
- Mar 6, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000013/prct-20260305.htm
- Feb 26, 2026: Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000007/prct-20260226.htm
- Feb 25, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/prct-20260225.htm
- Nov 4, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897825000049/prct-20251104.htm

## Insider trades (Form 4)

- Nov 6, 2026: Pooja Sharma (Chief Strat/Marketing Officer) sold 4,710 shares, about $92,853. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026071815/0001628280-26-071815-index.htm
- Sep 9, 2026: Kevin Waters (EVP, CFO) sold 373 shares, about $7,814. Source: https://www.sec.gov/Archives/edgar/data/1588978/000165377126000002/0001653771-26-000002-index.htm
- Sep 9, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 297 shares, about $6,222. Source: https://www.sec.gov/Archives/edgar/data/1588978/000159941826000002/0001599418-26-000002-index.htm
- Sep 9, 2026: Barry L. Templin (EVP, Chief Technology Officer) sold 373 shares, about $7,814. Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000032/0001588978-26-000032-index.htm
- Aug 7, 2026: Larry L. Wood (President, CEO) bought 23,900 shares, about $498,315. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026054970/0001628280-26-054970-index.htm
- Jun 8, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 285 shares, about $8,117. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026042223/0001628280-26-042223-index.htm
- Jun 8, 2026: Kevin Waters (EVP, CFO) sold 357 shares, about $10,167. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026042218/0001628280-26-042218-index.htm
- Jun 8, 2026: Barry L. Templin (EVP, Chief Technology Officer) sold 358 shares, about $10,196. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026042213/0001628280-26-042213-index.htm
- Mar 19, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 5,363 shares, about $139,242. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026019900/0001628280-26-019900-index.htm
- Mar 17, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 304 shares, about $8,558. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026019833/0001628280-26-019833-index.htm
- Mar 17, 2026: Kevin Waters (EVP, CFO) sold 706 shares, about $19,874. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026019830/0001628280-26-019830-index.htm
- Mar 10, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 3,243 shares, about $83,186. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026017218/0001628280-26-017218-index.htm
- Mar 9, 2026: Antal Rohit Desai (Director) bought 426,262 shares, about $10.5M. Source: https://www.sec.gov/Archives/edgar/data/1588978/000090514826001209/0000905148-26-001209-index.htm
- Mar 6, 2026: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold 6,892 shares, about $163,340. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026016153/0001628280-26-016153-index.htm
- Mar 6, 2026: Kevin Waters (EVP, CFO) sold 6,721 shares, about $159,288. Source: https://www.sec.gov/Archives/edgar/data/1588978/000162828026016151/0001628280-26-016151-index.htm

## What management said

- "As we enter the fourth quarter, we remain focused on executing against our full-year revenue guidance and profitability plan" Larry Wood, Chief Executive Officer (8-K filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000036/prct_q32026earningsrelease.htm

## Latest filings

- 8-K filed Oct 2, 2026: https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/prct-20261002.htm
- 10-K filed Feb 26, 2026: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/prct-20251231.htm
- 10-Q filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000030/prct-20260630.htm
- DEF 14A filed Apr 22, 2026: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000017/prct-20260422.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/